Free shipping on all orders over $ 500

TJ-M2010-5

Cat. No. M21680

All AbMole products are for research use only, cannot be used for human consumption.

TJ-M2010-5 Structure
Size Price Availability Quantity
1mg USD 32 In stock
5mg USD 75 In stock
10mg USD 110 In stock
25mg USD 220 In stock
50mg USD 380 In stock
100mg USD 580 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TJ-M2010-5 is a MyD88 inhibitor that binds to the TIR domain of MyD88 to interfere with its homodimerization, and the TLR/MyD88 signal pathway. TJ-M2010-5 inhibited MyD88 homodimerization in transfected HEK293 cells in a concentration-dependent manner and suppressed MyD88 signaling in LPS-responsive RAW 264.7 cells in vitro.

In a 10-week CAC mouse model (n = 30 per group), TJ-M2010-5 treatment statistically significantly reduced AOM/DSS-induced colitis and completely prevented CAC development with less related body mass loss, resulted in 0% mortality of treated mice (compared with 53% mortality of control mice), decreased cell proliferation, and increased apoptosis in colon tissue. TJ-M2010-5 treatment also inhibited production of inflammatory cytokines and chemokines (TNF-α, IL-6,G-CSF, MIP-1β, TGF-β1, IL-11, IL-17A, IL-22 and IL-23) and infiltration of immune cells (macrophages, dendritic cells, neutropihls and CD(+)4 T cells) in colon tissues of mice.

Protocol (for reference only)
Cell Experiment
Cell lines RAW 264.7 cells
Preparation method RAW 264.7 cells were cultured in RPMI medium 1640. After stimulation with 100ng/mL of lipopolysaccharide (LPS) for six hours with 40 µM TJ-M2010-5 or vehicle one hour pretreatment, cells in individual wells were harvested for protein extraction.
Concentrations 40 µM
Incubation time 6 hours
Animal Experiment
Animal models Female BalB/c mice (6–8 weeks old)
Formulation vehicle (ddH2 O)
Dosages 50mg/Kg daily
Administration i.p.
Chemical Information
Molecular Weight 406.54
Formula C23H26N4OS
CAS Number 1357471-57-8
Solubility (25°C) DMSO 90 mg/mL
Storage 4°C, protect from light, sealed
References

[1] Zeyang Li, et al. Front Pharmacol. TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway

[2] Huifang Yang, et al. J Cardiovasc Transl Res. TJ-M2010-5 Attenuates Severe Myocardial Ischemia/Reperfusion Injury in Heart Transplantation by Inhibiting MyD88 Homodimerization In Vivo

[3] Yalong Xie, et al. Chem Biol Interact. TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway

[4] Wei Zhou, et al. Int Immunopharmacol. Hypothermic oxygenated perfusion combined with TJ-M2010-5 alleviates hepatic ischemia-reperfusion injury in donation after circulatory death

[5] Yan Miao, et al. Am J Transl Res. Inhibition of MyD88 by a novel inhibitor reverses two-thirds of the infarct area in myocardial ischemia and reperfusion injury

[6] Zhimiao Zou, et al. Int Immunopharmacol. TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro

[7] Lin Xie, et al. J Natl Cancer Inst. Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer

Related Immunology/Inflammation Products
Laquinimod

Laquinimod (ABR-215062) is a new orally active immunoregulator effectively inhibits development and relapses of experimental autoimmune encephalomyelitis.

Cyclosporine A

Cyclosporine A (CsA,Cyclosporin A) is an immunosuppressant that binds to cyclophilin and inhibits calcineurin with an IC50 of 7 nM. Cyclosporine A [CsA] binds to the cyclophilin 18 (Cyp18)-CsA complex. the Cyp18-CsA complex recruits calcium-regulated neurophosphatase (CaN), leading to the blocking of cytokine gene transcription in activated T cells. CsA is a highly specific inhibitor of T-cell activation.

Pimecrolimus

Pimecrolimus is an immunomodulating agent used in the treatment of atopic dermatitis.

Meloxicam

Meloxicam (Mobic) is a nonsteroidal anti-inflammatory agent with analgesic and fever reducer effects.

Mycophenolic acid

Mycophenolic acid is an immunosuppressant agent used to prevent rejection in organ transplantation.

  Catalog
Abmole Inhibitor Catalog




Keywords: TJ-M2010-5 supplier, Immunology/Inflammation, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.